Pandemic’s Ecological Fallacy
The pandemic ushered in clinical studies that have changed healthcare policy. But the pace of publications also led to studies...
War Elephants of Healthcare
The original battle tanks of antiquity, war elephants were famed for the terror they inflicted on the battlefield. And equally...
Anatomy of a DEA Investigation
As the opioid epidemic rages on, DEA agents intensify their efforts to curtail the diversion of prescription medications.
Medical Devices are for the Startups
Most new medical devices are designed and developed by startups, only to be acquired by larger medical device corporations when...
Nonlinear Healthcare Models
For most businesses, the relationship between revenue and cost is defined in a straightforward unit economic model. In healthcare, this...
When Reddit Comes For Healthcare
We all know the impact Reddit has on the financial world. But how will Reddit's impact appear in the medical...
There’s a Vaccine For That
The COVIDization of healthcare will usher in new trends in healthcare, the most promising of which is the widespread use...
Rise of the Medical Licensing Boards
Mostly used to oversee licensing and disciplinary issues, each state's board holds a unique relationship with the state's attorney general's...
A New Approach to the Opioid Epidemic
The opioid epidemic is defined through statistics, which has influenced our approach to resolving it - with little success. We...
The Pandemic is a Perception
Healthcare data has proven to be of little value to both policy makers and to the public. Instead of data,...
Healthcare is a System
An obvious statement that most would agree with. Yet few understand systemic thinking in healthcare, which requires an understanding of...
COVID-19’s ‘Miracle’ Drugs
Another day, another miracle drug. Or so it seems. As seemingly every day we hear about new drugs touted as...
Semaglutide and the Expansion Problem: When One Trial Becomes a Platform
Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...
Read more